XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Sales:        
Total sales $ 13,147 $ 13,706 $ 28,817 $ 29,081
Cost of sales:        
Total cost of sales 8,940 7,228 20,046 18,508
Gross profit 4,207 6,478 8,771 10,573
Operating expenses:        
Engineering and development 763 726 1,549 1,426
Selling, general and administrative 4,438 4,518 8,570 8,256
Total operating expenses 5,201 5,244 10,119 9,682
Operating (loss) income (994) 1,234 (1,348) 891
Other income (expense):        
Foreign exchange (loss) gain (132) 32 163 (142)
Interest expense (77) (46) (154) (95)
Interest income 414 478 903 974
Other (expense) income, net (2) 25 2 35
Total other income, net 203 489 914 772
(Loss) income before income taxes (791) 1,723 (434) 1,663
Income tax (benefit) expense (683) 135 (798) 148
Net (loss) income (108) 1,588 364 1,515
Net (loss) income attributable to common shareholders $ (108) $ 1,482 $ 341 $ 1,417
Net (loss) income per common share - basic (in dollars per share) $ (0.01) $ 0.16 $ 0.04 $ 0.16
Weighted average common shares outstanding - basic (in shares) 9,343 9,070 9,232 8,967
Net (loss) income per common share - diluted (in dollars per share) $ (0.01) $ 0.16 $ 0.04 $ 0.15
Weighted average common shares outstanding - diluted (in shares) 9,343 9,455 9,614 9,366
Product        
Sales:        
Total sales $ 8,552 $ 8,458 $ 19,567 $ 19,865
Cost of sales:        
Total cost of sales 6,879 5,416 15,998 14,644
Service        
Sales:        
Total sales 4,595 5,248 9,250 9,216
Cost of sales:        
Total cost of sales $ 2,061 $ 1,812 $ 4,048 $ 3,864